Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Hypertension

Interventions

DRUG

Valsartan+/- Hydrochlorothiazide

Trial Locations (1)

Novartis Investigative Site, Singapore